DTIL
NASDAQ · Biotechnology
Precision Biosciences Inc
$7.86
-0.06 (-0.76%)
Open$7.90
Previous Close$7.92
Day High$8.34
Day Low$7.81
52W High$8.82
52W Low$3.53
Volume—
Avg Volume285.3K
Market Cap194.68M
P/E Ratio—
EPS$-3.67
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+290.5% upside
Current
$7.86
$7.86
Target
$30.69
$30.69
$21.79
$30.69 avg
$37.55
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 77.16M | 69.56M | 15.69M |
| Net Income | -102,968,460 | -83,540,623 | 557.5K |
| Profit Margin | -133.5% | -126.8% | 3.6% |
| EBITDA | -114,210,101 | -97,809,065 | 726.6K |
| Free Cash Flow | — | — | 441.5K |
| Rev Growth | +10.9% | +10.9% | -7.6% |
| Debt/Equity | 0.24 | 0.24 | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |